The Global Health Observatory

Explore a world of health data

Table Table
Indicator name:
Estimated pregnant women living with HIV who received antiretroviral medicine for preventing mother-to-child transmission (%)
Data type:
Percent
Indicator Id:
2932
Rationale:
The risk for mother-to-child transmission can be reduced significantly by the complementary approaches of providing antiretroviral drugs (as treatment or as prophylaxis) to the mother and antiretroviral prophylaxis to the infant and using safe delivery practices and safer infant feeding. The data will be used to track progress toward global and national goals towards elimination of mother-to-child transmission; to inform policy and strategic planning; for advocacy; and leveraging resources for accelerated scale up.
Definition:
Numerator: Number of HIV-positive pregnant women who received the most effective antiretroviral regimens as recommended by WHO (i.e. excluding single-dose nevirapine) during the past 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-positive pregnant women within the past 12 months.
Method of measurement
For the numerator: national programme records aggregated from programme monitoring tools, such as patient registers and summary reporting forms. For the denominator: estimation models such as Spectrum (software developed by WHO/UNAIDS), or antenatal clinic surveillance surveys in combination with demographic data and appropriate adjustments related to coverage of ANC surveys.  
Method of estimation:
Programme monitoring and HIV surveillance.
Indicator Metadata Registry List
Globally, there were 1.2 million [950 000–1.4 million] pregnant women with HIV in 2023, of which an estimated 84% [72–>98%] received antiretroviral drugs to prevent mother-to-child transmission.
If you have any feedback, you are welcome to write it here.
If you need to access the old Global Health Observatory data, you can do it here. But before you leave, please provide us your feedback about our new data portal.